Announcement on Holding the 1st Investor Reception Day 2026
Filed with SSE · · 5 pages · Chinese
Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix
Earlier from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Resignation of Senior Management Member
- Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Postponement of Disclosure of 2025 Annual Report
- Announcement on Not Revising Downward the Conversion Price of "Shouxiangu 22 Convertible Bonds"
Later from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Follow-up Rating Results of "Shouxiangu 22 Convertible Bonds" in 2026
- Announcement on Conversion Result of "Shouxiangu 22 Convertible Bond" and Share Changes
- Announcement on Change of Securities Affairs Representative
- Announcement on Resolutions of the 10th Meeting of the 5th Board of Directors
Follow Zhejiang Shouxiangu Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shouxiangu Pharmaceutical